Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem dose comparison in coronary slow flow phenomenon
ChiCTR-TRC-12002513Phase 4Recruiting
- Sponsor
- Wuhan Fourth Hospital
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of diltiazem in Slow Coronary Flow (SCF) (2 arms), sponsored by Wuhan Fourth Hospital. Primary endpoint: Symptom improvement. Started Oct 2012; status: recruiting.
02
Drugs
diltiazem
03
Conditions
Slow Coronary Flow (SCF)
Beyond the preview
Go deeper on ChiCTR-TRC-12002513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002513.